Survey of oncologists finds knowledge gap on medical marijuana
As more states legalize medical marijuana, two key groups — researchers whose job is it to understand its benefits and drawbacks, and physicians charged with advising potential users — are struggling to catch up with policymakers.
Ilana Braun, an assistant professor of psychiatry at Harvard Medical School and chief of the division of adult psychosocial oncology at the Dana-Farber Cancer Institute, led a survey of cancer physicians around the country, exploring their attitudes and actions on medical marijuana.
The survey was sent to 400 oncologists, with a 63 percent response rate. We asked Braun to outline her findings, which were published last month in the Journal of Clinical Oncology.
Stories you may be interested in
More baby boomers use medical marijuana, but they want their doctors to get wise to the risks and benefits
Baby boomers’ marijuana use has edged upward in the past decade, but recent research suggests some still have a hard time getting a hold of the drug. Older adults want more education, more research and greater openness with their health-care providers about using medical marijuana, according to a qualitative study of older cannabis users and non-users in…
Read More 
July Updates
In our quest to save medical marijuana clinics valuable time, Arfinn Med has continued to release new functionality that improves EMR workflows. This has led to the development of our new telehealth platform, new automated patient intake emails, and generating all state required documentation. Continuing on our quest, we are proud to release our new…
Read More 
More Treatment Options, Better Patient Outcomes
As more states start to pass medical marijuana legislation, patients benefit from having more options available to them regarding their treatment. In fact, a recent study from Columbia University’s Irving Medical Center found that, “States with active medical marijuana laws saw certain opioid prescription rates drop nearly 20 percent compared to states without medical marijuana…
Read More 
World Cancer Day – Shine a Light on the World
In 2018, it was estimated that 1,735,350 new cancer cases would be diagnosed in the United States and 609,640 individuals would pass from the disease [Cancer.gov]. We cannot sit by and ignore this life altering disease, which is why World Cancer Day, recognized on Feb. 4, is such an important awareness campaign to the Arfinn…
Read More 
Minnesota study finds that medical pot soothes cancer pains
Symptoms such as pain and nausea improved in cancer patients who took cannabis, according to new research that is part of Minnesota’s effort to address the information void about whether marijuana offers medical benefits. Analyzing 1,120 cancer patients who received cannabis through the state medical marijuana program, researchers reported Monday that they found noteworthy improvements…
Read More 
Doctors and patients are flying blind as medical marijuana use rises, research lags
Marijuana’s role in the health care universe has grown exponentially over the past few years. Currently, 33 U.S. states have legalized the use of medical marijuana, and more and more states are considering making it legal for recreational purposes as well. As cannabis becomes more accessible, many people are turning to tetrahydrocannabinol (THC) and cannabidiol (CBD) products to…
Read More